The Food and Drug Administration (FDA) reiterates to all licensed drugstores and pharmacies to sell drugs and medicines with physician’s prescription. This is in reference to the alleged abrupt increase in the purchase of Hydroxychloroquine related to its possible use for COV1D-1 9.
Hydroxychloroquine is an antimalarial drug also indicated and importantly used for the treatment of patients with chronic inflammatory diseases such as rheumatoid arthritis, juvenile inflammatory arthritis, and systemic lupus erythematosus.
The FDA appeals to the pharmacies to cater to patients with established indications of this drug. Amidst the challenges of the COVID-19 pandemic, we do not want to leave our patients who have other life threatening and debilitating diseases with nothing to use for their treatment.
Attachment:-> FDA Advisory No.2020-450